NCT06184100

Brief Summary

The aim of this project is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility and preliminary effectiveness of a virtual group based self-management program (SMP) in adolescents with JIA across different provinces compared to a wait-list control group receiving only standard of care. Participants in the SMP group will partake in four 60-90 minute group sessions conducted over 8 weeks. The intervention is a multifaceted program that includes JIA disease education, self-management strategies, and peer support. Both the interventional and control group will be asked to complete baseline and post-test measures. Participants in the control group will be offered the SMP after completion of the post-control outcome measures.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

December 13, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 28, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

December 9, 2024

Status Verified

October 1, 2024

Enrollment Period

2 years

First QC Date

November 10, 2023

Last Update Submit

December 4, 2024

Conditions

Keywords

VirtualEducationClinical TrialJIASelf-management Program

Outcome Measures

Primary Outcomes (3)

  • Program Adherence Rates (feasability)

    The primary objective is feasibility outcome that will be measured as adherence with the SMP Program. This is defined as Proportion of completed questionnaires (defined as 80% when all measures are completed) at baseline and 8 weeks post-randomization in both groups along with recruitment and withdrawal rates. (\>80% recruitment rate and \<80% withdrawal)

    3 months

  • Satisfaction of Program

    Satisfaction with the SMP as measured through a semi-structured virtual interview with the participants following involvement in the SMP to capture participants' experience.

    3 months

  • Intervention fidelity

    We are looking at consistent content and technology delivery. This will be assessed by i) Observational checklists ii) qualitative analysis of recorded video sessions after 2, 4 and at completion of all sessions by each facilitator to ensure sessions are consistently delivered and as planned.

    3 months

Secondary Outcomes (5)

  • Understanding of JIA

    3 months

  • Understanding of Arthritis Self Efficacy

    3 months

  • Quality of Life for Teens

    3 months

  • Physical Pain Level

    3 months

  • How Prepared the patient feels for Adult Care

    3 months

Study Arms (2)

SMP Program with Standard Care

EXPERIMENTAL

four 60-90 minute virtual educational sessions over 8 weeks with a group of 4-6 participants

Other: Virtual Self-Management Program (SMP)

Standard Care Only

ACTIVE COMPARATOR

Standard of care(no formal education program similar to SMP) and placed on 8-week waitlist for optional intervention.

Other: No Intervention

Interventions

Four sessions, 60-90 minutes each, will be conducted over eight weeks with a group size of 4-6 participants via videoconferencing platforms such as Zoom or Microsoft Teams. Each session will include Power Point delivered presentations, interactive activities, and group discussions. This is a multifaceted program that includes JIA disease education, self-management strategies, and peer support.

SMP Program with Standard Care

No intervention. Participant only receives standard of care.

Standard Care Only

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Adolescents between the ages of 12 and 17
  • Confirmed diagnosis within 2 years according to the International League of Associations for Rheumatology JIA classification criteria (2)
  • Followed in one of the pediatric rheumatology clinics participating in the RCT
  • Able to access the Internet on a computer
  • Willing and able to complete online measures

You may not qualify if:

  • Insufficient English reading and speaking skills
  • Untreated psychiatric or comorbid disorders or major cognitive impairments leading to inability to understand materials and participate in the SMP group activities.
  • Other chronic conditions such as other autoimmune disease, neurologic, orthopedics or other systems disorder (e.g. heart, kidney) that might influence outcome assessments
  • Past participation in the last year or participating in another peer-support or self-management program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alberta Children's Hospital

Calgary, Alberta, T3B 6A8, Canada

RECRUITING

Related Publications (1)

  • Booth J, Birnie KA, Chomistek K, Santana M, Stinson JN, Adebiyi BO, Brooks J, Guzman J, Hellweg R, Lim LS, Rumsey D, Feldman BM, Tagseth J, Wilson J, Schmeling H. A Virtual Self-Management Intervention for Adolescents With Juvenile Idiopathic Arthritis: Protocol for the VISTA-JIA Randomized Controlled Trial. JMIR Res Protoc. 2025 Jun 27;14:e69539. doi: 10.2196/69539.

MeSH Terms

Conditions

Arthritis, Juvenile

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The research team and all participants will be aware which arm they are enrolled in throughout the study.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Patients will be randomized into an interventional or control group. The control group will be given the option to receive the intervention after post-test outcome measures are recorded.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2023

First Posted

December 28, 2023

Study Start

December 13, 2023

Primary Completion

December 1, 2025

Study Completion

March 1, 2026

Last Updated

December 9, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations